NCT05826509 2026-01-15
SUGAR
Institut Claudius Regaud
Phase 2 Active not recruiting
Clinical Trials
26 trialsNCT04286386 2025-10-27
Development and Evaluation of a Quantitative HP MRI for Clinical Prostate Cancer Exam
M.D. Anderson Cancer Center
Active not recruiting
NCT03978624 2025-10-15
Window of Opportunity Study of Pembrolizumab Alone and in Combinations in Bladder Cancer
UNC Lineberger Comprehensive Cancer Center
Phase 2 Active not recruiting
NCT06427824 2025-10-03
Comprehensive Geriatric Assessment (Tests) for Bladder Cancer Participants Undergoing Radical Cystectomy
University of Chicago
Phase NA Recruiting
NCT06834321 2025-09-08
Clinical Study on Neoadjuvant Therapy of Homoharringtonine Combined With Androgen Deprivation for Prostate Cancer
Zhongda Hospital
Phase 2 Recruiting
NCT05448547 2025-07-01
GrandP/SPCG19
The Hospital of Vestfold
Phase 3 Recruiting
NCT00938145 2025-04-11
3 Tesla MRI in Patients With Bladder Cancer
University of Cincinnati
Phase NA Active not recruiting
NCT06341933 2025-01-30
Risk Factors for AKI in Patients Undergoing VATS for Pulmonary Resection
Atatürk Chest Diseases and Chest Surgery Training and Research Hospital
Recruiting
NCT04228042 2025-01-01
Infigratinib Before Surgery for the Treatment of Upper Tract Urothelial Cancer
M.D. Anderson Cancer Center
Phase 1/2 Terminated
NCT06531629 2024-08-06
Risk-based Screen and Prognostic Analysis for Second Primary Malignancies in Kidney Cancer Patients
Peking University First Hospital
Completed
NCT06350825 2024-04-05
Cytoreductive Prostatectomy Combined With Triple or Dual Systemic Therapy in mHSPC Patients
The First Affiliated Hospital with Nanjing Medical University
Phase 3 Recruiting
NCT06278506 2024-02-26
RESTART
Karolinska University Hospital
Phase NA Recruiting
NCT05578664 2023-08-30
PE-PE
Consorzio Oncotech
Phase 2 Unknown
NCT01751438 2023-04-27
Best Systemic Therapy or Best Systemic Therapy (BST) Plus Definitive Treatment (Radiation or Surgery)
M.D. Anderson Cancer Center
Phase 2 Completed
NCT00430183 2023-02-09
Surgery With or Without Docetaxel and Leuprolide or Goserelin in Treating Patients With High-Risk Localized Prostate Cancer
Alliance for Clinical Trials in Oncology
Phase 3 Active not recruiting
NCT02572284 2023-01-19
Dose Escalation Study of Preoperative SBRT for High Risk Prostate Cancer
H. Lee Moffitt Cancer Center and Research Institute
Phase 1 Completed
NCT05082818 2022-06-14
Outcome of Treating Bladder Cancer in Sohag University Hospital
Sohag University
Completed
NCT04718948 2022-05-09
Multimodal Spectroscopy to Detect Urothelial Cancer in Urine
University of Florence
Unknown
NCT02102477 2022-03-31
SPCG-15
Karolinska University Hospital
Phase NA Recruiting
NCT04946266 2022-01-05
MFI2-PREDICT
University Hospital, Strasbourg, France
Unknown
NCT04588168 2020-10-19
Multi-parameter Magnetic Resonance Imaging Guides Precise Treatment of Urothelial Carcinoma
The First Affiliated Hospital with Nanjing Medical University
Phase NA Recruiting
NCT02716896 2019-11-25
Radical Cystectomy Compared With Chemoradiation for Muscle Invasive Bladder Cancer
The University of Texas Health Science Center at San Antonio
Phase NA Terminated
NCT00023686 2016-07-06
Surgery Versus Internal Radiation in Treating Patients With Stage II Prostate Cancer
Alliance for Clinical Trials in Oncology
Phase 3 Completed
NCT01608165 2015-12-07
CONSERVE
Newcastle-upon-Tyne Hospitals NHS Trust
Phase NA Completed
NCT00491621 2015-06-04
CMM
Centre Hospitalier Universitaire de Saint Etienne
Phase NA Terminated
NCT00003585 2013-12-10
Biological Therapy Plus Chemotherapy in Treating Patients With Metastatic or Recurrent Kidney Cancer
University of New Mexico
Phase 1/2 Completed